title: Role of FAS in HIV infection.
abstract: Direct cytopathic effects cannot explain the massive CD4+ T cell depletion in acquired immunodeficiency syndrome (AIDS) patients and several indirect mechanisms may be involved. A role has been proposed for apoptosis of uninfected lymphocytes, since lymphocytes from human immunodeficiency virus-1+ (HIV-1) individuals display increased levels of spontaneous apoptosis. This process may be ascribed in part to cell exhaustion by the chronic uncontrolled infection, but can also be directly induced by viral components, such as gp120, tat or nef. A key role is played by the death receptor Fas, but a role can also be played by other death receptors, such as the TNF and TRAIL receptors. By contrast, death of HIV-infected cells seems to be Fas-independent and driven by other viral components such as vpr and HIV proteases. A further role may be played by depletion of CD4+ T cell itself and hence the withdrawal of survival factors such as cytokines. Different ability of HIV strains to induce death of infected and uninfected cells might play a role in the clinical and biological differences displayed by HIV strains. A further variability may be ascribed to the intrinsic resistance of cells to apoptosis, which may depend on the individual genetic background or the use of drugs inhibiting apoptosis. The observation that when progression of HIV infection is slow due to "apoptosis-resistant" genetic backgrounds of the patients, or defective HIV-1 strains, or successful highly active antiretroviral therapy (HAART), generally also T cell apoptosis is low, suggests that HIV-infected subjects may benefit from therapies aimed to inhibit Fas function and/or spontaneous apoptosis.
authors.affiliation: Interdisciplinary Research Center of Autoimmune Diseases, Department of Medical Sciences, A. Avogadro University of Eastern Piedmont, Novara, Italy. dianzani@med.unipmn.it
authors.forename: Umberto
authors.initials: U
authors.lastname: Dianzani
authors.forename: Thea
authors.initials: T
authors.lastname: Bensi
authors.forename: Andrea
authors.initials: A
authors.lastname: Savarino
authors.forename: Selina
authors.initials: S
authors.lastname: Sametti
authors.forename: Manuela
authors.initials: M
authors.lastname: Indelicato
authors.forename: Riccardo
authors.initials: R
authors.lastname: Mesturini
authors.forename: Annalisa
authors.initials: A
authors.lastname: Chiocchetti
mesh_terms: D017209:Apoptosis; D018791:CD4 Lymphocyte Count; D015496:CD4-Positive T-Lymphocytes / Q000821:virology; D053222:Fas Ligand Protein; D015658:HIV Infections / Q000276:immunology / Q000473:pathology / Q000503:physiopathology* / Q000821:virology; D015497:HIV-1; D006801:Humans; D008562:Membrane Glycoproteins / Q000502:physiology; D009336:Necrosis; D018124:Receptors, Tumor Necrosis Factor / Q000502:physiology; D015398:Signal Transduction; D014764:Viral Proteins / Q000502:physiology; D019014:fas Receptor / Q000502:physiology*
chemical_list: C505661:FASLG protein, human; D053222:Fas Ligand Protein; D008562:Membrane Glycoproteins; D018124:Receptors, Tumor Necrosis Factor; D014764:Viral Proteins; D019014:fas Receptor